Sandoz targets mid-to-high single-digit sales growth through 2030
Sandoz Group set a sales growth outlook for 2030, targeting mid-to-high single-digit growth.
Story updates
05:20:47 AM UTC
SquawkNews
Swiss generic drug maker Sandoz BX:D8Y is aiming to more than double its net sales from 2025 to 2035, the company said on Tuesday at its capital markets day.Sandoz said it is now also targeting annual net sales growth at a mid-to-high single-digit rate at constant currencies from 2025 to 2030 as it…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.